BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37019808)

  • 21. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?
    Calò PG; Pisano G; Medas F; Marcialis J; Gordini L; Erdas E; Nicolosi A
    World J Surg Oncol; 2014 May; 12():152. PubMed ID: 24885654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
    Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
    Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
    Decaluwé H; Stanzi A; Dooms C; Fieuws S; Coosemans W; Depypere L; Deroose CM; Dewever W; Nafteux P; Peeters S; Van Veer H; Verbeken E; Van Raemdonck D; Moons J; De Leyn P;
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):110-7. PubMed ID: 26819286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
    Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
    Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer†.
    Decaluwé H; Petersen RH; Brunelli A; Pompili C; Seguin-Givelet A; Gust L; Aigner C; Falcoz PE; Rinieri P; Augustin F; Sokolow Y; Verhagen A; Depypere L; Papagiannopoulos K; Gossot D; D'Journo XB; Guerrera F; Baste JM; Schmid T; Stanzi A; Van Raemdonck D; Bardet J; Thomas PA; Massard G; Fieuws S; Moons J; Dooms C; De Leyn P; Hansen HJ;
    Eur J Cardiothorac Surg; 2018 Feb; 53(2):359-365. PubMed ID: 29029062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.
    Hay ID; Bergstralh EJ; Grant CS; McIver B; Thompson GB; van Heerden JA; Goellner JR
    Surgery; 1999 Dec; 126(6):1173-81; discussion 1181-2. PubMed ID: 10598204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Larger tumor size predicts nodal involvement in patients with follicular thyroid carcinoma.
    Pisanu A; Deplano D; Pili M; Uccheddu A
    Tumori; 2011; 97(3):296-303. PubMed ID: 21789006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodal upstaging evaluation in NSCLC patients treated by robotic lobectomy.
    Zirafa C; Aprile V; Ricciardi S; Romano G; Davini F; Cavaliere I; Alì G; Fontanini G; Melfi F
    Surg Endosc; 2019 Jan; 33(1):153-158. PubMed ID: 29943062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.
    Werntz RP; Smith ZL; Packiam VT; Smith N; Steinberg GD
    Eur Urol Focus; 2020 Mar; 6(2):292-297. PubMed ID: 30297221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-risk differentiated thyroid cancer: the need for selective treatment.
    Shaha AR; Shah JP; Loree TR
    Ann Surg Oncol; 1997 Jun; 4(4):328-33. PubMed ID: 9181233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival.
    Olecki EJ; Stahl KA; Torres MB; Peng JS; Shen C; Dixon MEB; Gusani NJ
    J Surg Oncol; 2021 Jul; 124(1):79-87. PubMed ID: 33836095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The number of lymph nodes examined is associated with survival outcomes and nodal upstaging in patients with stage I small cell lung cancer.
    Chen Y; Zhang J; Jiang C; Zhang H; Fan P; Yu H; Zhang H; Fei K; Zhang P
    Surg Oncol; 2021 Jun; 37():101513. PubMed ID: 33429326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer.
    Alzahrani AS; Al Mandil M; Chaudhary MA; Ahmed M; Mohammed GE
    Surgery; 2002 Apr; 131(4):443-9. PubMed ID: 11935135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer.
    Hennon MW; DeGraaff LH; Groman A; Demmy TL; Yendamuri S
    Eur J Cardiothorac Surg; 2020 May; 57(5):888-895. PubMed ID: 31764992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer.
    Okumus Ö; Mardanzai K; Plönes T; Theegarten D; Darwiche K; Schuler M; Nensa F; Hautzel H; Hermann K; Stuschke M; Hegedus B; Aigner C
    Lung Cancer; 2023 Feb; 176():82-88. PubMed ID: 36623341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer.
    Rucker AJ; Raman V; Jawitz OK; Voigt SL; Tong BC; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2020 Dec; 110(6):1854-1860. PubMed ID: 32544452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
    Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M
    Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.